medline.ch Respirationstrakt Neoplasie

	Extended Anticoagulation Therapy With Rivaroxaban for Cancer-Associated Low-Risk Pulmonary Embolism According to Different Performance Status Scores: Insights From the ONCO PE Randomized Trial. J Am Heart Assoc Xiong W, Yamashita Y, Morimoto T, Muraoka N, Shioyama W, Nakagawa Y, Chatani R, Yamamoto H, Shibata T, Morikawa N, Fukumoto Y, Nishimoto Y, Ono K, Kimura T, ONCO PE Trial Investigators. PMID: 41757461 [PubMed - as supplied by publisher]
	Risk factors for atrial fibrillation after lung cancer surgery: a meta-analysis. Front Cardiovasc Med Zhang J, Liu S, Li J, Wang Y, Ni M, Jiang C, Huang S, Guo Z. PMID: 41756510 [PubMed - in process]
	Correction: TROPION-Lung10: a phase 3 study of datopotamab deruxtecan and rilvegostomig in patients with treatment-naÃ¯ve locally advanced or metastatic nonsquamous non-small cell lung cancer with high PD-L1 expression and without actionable genomic alterations. Front Oncol Frontiers Production Office. PMID: 41756332 [PubMed - in process]
	Lung adenocarcinoma with KRAS-Q61H: clinicopathologic features, diagnostics, and the evolving treatment landscape. Front Oncol Serafimidis I. PMID: 41756324 [PubMed - in process]
	Evaluation of the Dose Distribution Robustness for Lung Tumor Tracking in Robotic Radiotherapy Using Four-Dimensional Computed Tomography. Cureus Miyabe Y, Yamanaka H, Seki H, Iwata H, Mizoe J. PMID: 41755961 [PubMed]
	Rationale for the Nodule Management Protocol of the Australian National Lung Cancer Screening Program. J Med Imaging Radiat Oncol McCusker MW, Ellis S, Pascoe DM, Jones CM, Melsom S, McWilliams A, Leong TL, Marshall H, Fong KM, Brims FJH, Siemienowicz M. PMID: 41755713 [PubMed - as supplied by publisher]
	Measuring the Validity of Survey Questions on Breast, Cervical, Colorectal, and Lung Cancer Screening. Am J Epidemiol Kessler LG, Comstock B, Aiello Bowles EJ, Mou J, Nash MG, Bravo P, Fleckenstein LE, Pflugeisen C, Gao H, Winer RL, Ornelas IJ, Smith C, Neslund-Dudas C, Shetty P, Raghavan UG. PMID: 41755645 [PubMed - as supplied by publisher]
	Artificial Intelligence in Lung Cancer: A Narrative Review of Recent Advances in Diagnosis, Biomarker Discovery, and Drug Development. Pharmaceutics Basety S, Gudepu R, Velidandi A. PMID: 41754942 [PubMed]
	Nanotechnology-Enabled Precision Therapy for Lung Cancer in Never-Smokers. Pharmaceutics Cojocaru C, , Cojocaru R, Cojocaru E. PMID: 41754905 [PubMed - in process]
	Comparative Risks of Pneumonitis Amongst Immune Checkpoint Inhibitors in Patients with Lung Cancer: A Network Meta-Analysis of Randomized Clinical Trials. Pharmaceuticals (Basel) Ebzee RAR, Abubeker IY, Aboughalia A, Danjuma MI. PMID: 41754762 [PubMed - in process]
	Mean Corpuscular Volume as a Prognostic Marker in Patients with Non-Small Cell Lung Cancer Undergoing Surgical Resection: A Cohort Study. Medicina (Kaunas) An S, Eo W. PMID: 41752793 [PubMed - in process]
	Preoperative Advanced Lung Cancer Inflammation Index as a Potential Marker for Incidental Gallbladder Carcinoma: A Matched Case-Control Study. Medicina (Kaunas) Korkmaz YY, Aydin O, Karatay H, Korkmaz MS, Peker S, Gungor F, Kinaci E. PMID: 41752669 [PubMed - in process]
	A Circulating Signature of Tumour Hybrid Cells and Immune Checkpoints Predicts Metastatic Progression in Lung Cancer. Int J Mol Sci Sáenz de Santa María-Diez G, Liana Pardo-Prieto S, Lozano-Rodríguez R, Aguirre-Larracoechea U, Corpa-Rodríguez ME, Del Prado-Montero J, Terrón-Arcos V, Montalbán-Hernández K, Arvelo-Rosario D, Fernández-Felipe J, Córdoba L, Bonel-Pérez GC, Del Fresno C, Hurtado-Navarro L, López-Collazo E. PMID: 41752130 [PubMed - in process]
	The Dynamic Gut Microbiota: Monitoring Alterations During Lung Cancer Progression for Diagnosis and Precision Medicine. Int J Mol Sci Xiao X, Wang Y, Yin T, Wang Q, Feng Y, Ren H, Li J, Cheng L. PMID: 41752041 [PubMed - in process]
	Genomic Profile of Non-Small Cell Lung Cancer in a Spanish Cohort: A 2-Year Descriptive Study Using Next-Generation Sequencing. Genes (Basel) Carnero-Gregorio M, Perera-Gordo E, de la Peña-Castro V, Fernández-Gómez A, Rodríguez-Cerdeira C. PMID: 41751593 [PubMed - in process]
	CXCR4: A Promising Novel Strategy for Lung Cancer Treatment. Biomolecules Liao M, Wu J, Dai T, Liu G, Zhang J, Zhu Y, Xu L, Zhao J. PMID: 41750259 [PubMed - in process]
	Predictors of Pre- and Postoperative Quality of Life and Overall Survival in Patients with Non-Small Cell Lung Cancer: A Prospective Study. Cancers (Basel) Fukai R, Nishida T, Yamaguchi N, Sugimoto H, Fukui T, Noma S, Hibino M, Horiuchi S, Kondo T, Asou K, Shimizu E, Teshima S, Minagawa Y, Tsukiyama T. PMID: 41749967 [PubMed]
	Deep-Learning-Based Classification of Lung Adenocarcinoma and Squamous Cell Carcinoma Using DNA Methylation Profiles: A Multi-Cohort Validation Study. Cancers (Basel) Almufareh MF, Tehsin S, Humayun M, Kausar S, Farooq A. PMID: 41749859 [PubMed]
	The Role of the Oral Microbiome in Modulating Therapeutic Outcomes in Lung Cancer: Key Commensals and Clinical Implications. Cancers (Basel) Pertiwi TH, Suraya R, Akashi M, Nagano T. PMID: 41749850 [PubMed]
	Lung Cancer Screening in Adults: State-of-the-Art and Policy Mapping (2025). Cancers (Basel) Firmani G, Dolcini J, Chiavarini M, Barbadoro P. PMID: 41749848 [PubMed]

Artikel 1 - 20 / 157557

Seite 1 von 7878



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung